Combination of IFNγ and chemotherapeutic agents increase trail sensitivity of neuroblastoma cell lines

European Journal of Pediatric Surgery

Volumn 21, Issue 5, 2011, Pages 304-309

  Tong, H X ^a   Lu, C W ^a   Wang, Q S ^a   Ma, L Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

caspase 8; death receptor; neuroblastoma; TRAIL

Indexed keywords

CASPASE 8; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; COLORIMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 8; CELL LINE, TUMOR; DOXORUBICIN; ETOPOSIDE; HUMANS; INTERFERON-GAMMA; NEUROBLASTOMA; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 80055041772     PISSN: 09397248     EISSN: 1439359X     Source Type: Journal    
DOI: 10.1055/s-0031-1279762     Document Type: Article

References (20)

1. Fulda S, Debatin KM. IFNγ gamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 2002 21 2295-2308 (Pubitemid 34407289)
2. 2 also contributes to TRAIL resistance in neuroblastoma. Cancer Res 2003 63 1122-1129 (Pubitemid 36278447)
3. Fulda S, Debatin KM. Modulation of TRAIL signaling for cancer therapy. Vitam Horm 2004 67 275-290 (Pubitemid 39753668)
4. Tong HX, Lu CW, Yang YM et al,. Role of caspase 8 as a determinant in TRAIL sensitivity of neuroblastoma cell lines. Pediatr Hemat Oncol 2009 26 549-559
5. Tong HX, Lu CW, Zhang JH et al,. Enhanced effect of IFNγ on the induced-apoptosis of neuroblastoma cells by cytotoxic drugs. Pediatr Hemat Oncol 2008 25 549-558
6. Tong HX, Lu CW, Zhang JH et al,. Combination of -Interferon with TRAIL and cisplatin or etoposide induces apoptosis in neuroblastoma cell line SH-SY5Y. Chin Med Sci J 2007 22 38-43
7. Ebinger M, Senf L, Wachowski O et al,. Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma. Pathol Oncol Res 2004 10 17-21 (Pubitemid 38506607)
8. Fulda S, Debatin KM. 5-Aza-2-deoxycytidine and IFNγ-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 2006 25 5125-5133 (Pubitemid 44285981)
9. Tekautz TM, Zhu K, Grenet J et al,. Evaluation of IFNγ-gamma effects on apoptosis and gene expression in neuroblastoma preclinical studies. Biochim Biophys Acta 2006 1763 1000-1010 (Pubitemid 44488565)
10. Stupack DG, Teitz T, Potter MD et al,. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006 439 95-99 (Pubitemid 43053635)
11. McKee AE, Thiele CJ. Targeting caspase 8 to reduce the formation of metastases in neuroblastoma. Expert Opin Ther Targets 2006 10 703-708 (Pubitemid 44479978)
12. Wang MJ, Liu YX, Li XL et al,. Chemotherapeutic drugs enhanced rsTRAIL tumoricidal activity. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004 26 524-528
13. Kim YH, Lee YJ. Time sequence of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin treatment is responsible for a complex pattern of synergistic cytotoxicity. J Cell Biochem 2006 98 1284-1295 (Pubitemid 44128366)
14. Day TW, Wu CH, Safa AR. Etoposide induces protein kinase Cdelta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells. Mol Pharmacol 2009 76 632-640
15. Frese S, Frese-Schaper M, Andres AC et al,. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res 2006 66 5867-5874 (Pubitemid 43927141)
16. Karacay B, Sanlioglu S, Griffith TS et al,. Inhibition of the NF-kappa-B pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells. Cancer Gene Ther 2004 11 681-690 (Pubitemid 39299208)
17. van der Sloot AM, Tur V, Szegezdi E et al,. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor. Proc Natl Acad Sci USA 2006 103 8634-8639 (Pubitemid 43878072)
18. Jin H, Yang R, Fong S et al,. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Cancer Res 2004 64 4900-4905 (Pubitemid 38924535)
19. Liu P, Mao H, Hou P. Synergistic antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand combined with cisplatin in ovarian carcinoma cell lines in vitro and in vivo. Int J Gynecol Cancer 2006 16 538-548
20. Song K, Benhaga N, Anderson RL et al,. Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. Cancer Res 2006 66 6304-6311